PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre clinical and commercial development of novel neurological drug delivery systems for post operative pain. PixarBio researches and develops targeted delivery systems for drugs, cells, or biologics to treat pain, epilepsy, Parkinson s disease, and spinal cord injury. Our lead product platform, NeuroRelease, is an extended drug release microparticle platform that is non opiate, non addictive for post surgical pain treatment. In pre clinical models NeuroRelease has the potential to achieve months of sustained therapeutic release of non opiate drugs for post operative, acute and chronic pain.
Quote | PixarBio Corp (OTCMKTS:PXRB)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 100 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | PixarBio Corp (OTCMKTS:PXRB)
Message Board Posts | PixarBio Corp (OTCMKTS:PXRB)
Subject | By | Source | When |
---|---|---|---|
Getting judgement and getting restitution are two different | cantwate | investorshub | 09/16/2020 2:27:25 PM |
https://www.sec.gov/litigation/litreleases/2020/lr24897.htm | lucky, mydog | investorshub | 09/15/2020 3:51:02 PM |
Was anyone on todays conference call? | cantwate | investorshub | 01/13/2020 8:01:23 PM |
https://www.sec.gov/litigation/litreleases/2019/lr24395.htm | Ole Broke Azz | investorshub | 02/12/2019 12:16:26 AM |
When is Frank Reynolds finally going to go | voisybay123 | investorshub | 12/24/2018 9:06:43 PM |
News, Short Squeeze, Breakout and More Instantly...